EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 31 / Numéro 1 (Janvier 2015) Med Sci (Paris), 31 1 (2015) 60-67 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 1, Janvier 2015
Page(s) 60 - 67
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153101014
Publié en ligne 6 février 2015
  1. Dalmau J, Tüzün E, Wu H, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007 ; 61 : 25–36. [CrossRef] [PubMed] [Google Scholar]
  2. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008 ; 7 : 1091–1098. [CrossRef] [PubMed] [Google Scholar]
  3. Zandi MS, Irani SR, Lang B, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011 ; 258 : 686–688. [CrossRef] [PubMed] [Google Scholar]
  4. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010 ; 167 : 261–280. [CrossRef] [PubMed] [Google Scholar]
  5. Miller BJ, Buckley P, Seabolt W, et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011 ; 70 : 663–671. [CrossRef] [PubMed] [Google Scholar]
  6. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature 2009 ; 460 : 744–747. [PubMed] [Google Scholar]
  7. Benros ME, Eaton WW, Mortensen PB. The epidemiologic evidence linking autoimmune diseases and psychosis. Biol Psychiatry 2014 ; 75 : 300–306. [CrossRef] [PubMed] [Google Scholar]
  8. Henneberg AE, Horter S, Ruffert S. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients. Schizophr Res 1994 ; 14 : 15–22. [CrossRef] [PubMed] [Google Scholar]
  9. Kantrowitz JT, Javitt DC. N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia ? Brain Res Bull 2010 ; 83 : 108–121. [CrossRef] [PubMed] [Google Scholar]
  10. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011 ; 10 : 63–74. [CrossRef] [PubMed] [Google Scholar]
  11. Tsutsui K, Kanbayashi T, Tanaka K, et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 2012 ; 12 : 37. [CrossRef] [PubMed] [Google Scholar]
  12. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013 ; 70 : 271–278. [CrossRef] [PubMed] [Google Scholar]
  13. Hammer C, Stepniak B, Schneider A, et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 2014 ; 19 : 1143–1149. [CrossRef] [PubMed] [Google Scholar]
  14. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010 ; 10 : 835–844. [CrossRef] [PubMed] [Google Scholar]
  15. Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011 ; 10 : 759–772. [CrossRef] [PubMed] [Google Scholar]
  16. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the california encephalitis project. Clin Infect Dis 2012 ; 54 : 899–904. [CrossRef] [PubMed] [Google Scholar]
  17. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013 ; 12 : 157–165. [CrossRef] [PubMed] [Google Scholar]
  18. Kayser MS, Titulaer MJ, Gresa-Arribas N, et al. Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 2013 ; 70 : 1133–1139. [CrossRef] [PubMed] [Google Scholar]
  19. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009 ; 28 : 1421–1429. [CrossRef] [PubMed] [Google Scholar]
  20. Prüss H, Finke C, Höltje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012 ; 72 : 902–911. [CrossRef] [PubMed] [Google Scholar]
  21. Moscato EH, Jain A, Peng X, et al. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci 2010 ; 32 : 298–309. [CrossRef] [PubMed] [Google Scholar]
  22. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010 ; 133 : 1655–1667. [CrossRef] [PubMed] [Google Scholar]
  23. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014 ; 13 : 167–177. [CrossRef] [PubMed] [Google Scholar]
  24. Verhelst H, Verloo P, Dhondt K, et al. Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster. Eur J Paediatr Neurol 2011 ; 15 : 163–166. [CrossRef] [PubMed] [Google Scholar]
  25. Zhang Q, Tanaka K, Sun P, et al. Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis 2012 ; 45 : 610–615. [CrossRef] [PubMed] [Google Scholar]
  26. Pollak TA, McCormack R, Peakman M, et al. Prevalence of anti-N-methyl-d-aspartate (NMDA) antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychol Med 2014 ; 44 : 2475–2487. [CrossRef] [PubMed] [Google Scholar]
  27. Masdeu JC, González-Pinto A, Matute C, et al. Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry 2012 ; 169 : 1120–1121. [CrossRef] [PubMed] [Google Scholar]
  28. Titulaer MJ, Dalmau J. Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: a theory with unproven links. Mol Psychiatry 2014 ; 19 : 1054. [CrossRef] [Google Scholar]
  29. Najjar S, Pearlman DM, Alper K, et al. Neuroinflammation and psychiatric illness. J Neuroinflammation 2013 ; 10 : 43. [CrossRef] [PubMed] [Google Scholar]
  30. Creten C, van der Zwaan S, Blankespoor RJ, et al. Late onset autism and anti-NMDA-receptor encephalitis. Lancet 2011 ; 378 : 98. [CrossRef] [PubMed] [Google Scholar]
  31. Caplan JP, Binius T, Lennon VA, et al. Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics 2011 ; 52 : 501–506. [CrossRef] [PubMed] [Google Scholar]
  32. Lebon S, Mayor-Dubois C, Popea I, et al. Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis mimicking a primary psychiatric disorder in an adolescent. J Child Neurol 2012 ; 27 : 1607–1610. [CrossRef] [PubMed] [Google Scholar]
  33. Choe C, Karamatskos E, Schattling B, et al. A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder. Psychiatry Res 2013 ; 208 : 194–196. [CrossRef] [PubMed] [Google Scholar]
  34. Busse S, Busse M, Brix B, et al. Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients. Eur Arch Psychiatry Clin Neurosci 2014 ; 264 : 545–550. [CrossRef] [PubMed] [Google Scholar]
  35. Dickerson F, Stallings C, Vaughan C, et al. Antibodies to the glutamate receptor in mania. Bipolar Disord 2012 ; 14 : 547–553. [CrossRef] [PubMed] [Google Scholar]
  36. Lauvsnes MB, Omdal R. Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. J Neurol 2012 ; 259 : 622–629. [CrossRef] [PubMed] [Google Scholar]
  37. Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain J Neurol 2012 ; 135 : 1606–1621. [CrossRef] [PubMed] [Google Scholar]
  38. Rhoads J, Guirgis H, McKnight C, Duchemin AM. Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schirophrenia. Schizophr Res 2011 ; 129 : 213–214. [CrossRef] [PubMed] [Google Scholar]
  39. Haussleiter IS, Emons B, Schaub M, et al. Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic pateints. Schizophr Res 2012 ; 140 : 258–259. [CrossRef] [PubMed] [Google Scholar]
  40. Gielen M.. Fonctionnement des récepteurs-canaux du glutamate. Med Sci (Paris) 2010 ; 26 : 65–72. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  41. Jacob L, Dauvilliers Y. La narcolepsie : une maladie auto-immune ? Med Sci (Paris) 2014 ; 30 : 1136–1143. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.